July - 20216July - 12 - 2021, volume 04 - Issue 27 (ISSN 2691-4093)Published by ValleyMedia, Inc. Managing EditorAlex D'souzaEditorial StaffVisualizerJohn GothamSalesAndrew D'Souzaandrew.dsouza@medicaltechoutlook.com510.996.5123Contact usEmailPhone:510 230 0396 Fax:510-894-8405sales@medicaltechoutlook.comeditor@medicaltechoutlook.commarketing@medicaltechoutlook.comJoshua Parker Merlin WatsonJoe Philip Laura PintoTo subscribe to MedicalTech OutlookVisit www.medicaltechoutlook.com Copyright © 2021 ValleyMedia Inc. All rights reserved. Reproduction in whole or part of any text, photography or illustrations without written permission from the publisher is prohibited. The publisher assumes no responsibility for unsolicited manuscripts, photographs or illustrations. Views and opinions expressed in this publication are not necessarily those of the magazine and accordingly, no liability is assumed by the publisher thereof.*Some of the Insights are based on the interviews with respective CIOs and CXOs to our editorial staffAlex D'souzaManaging Editoreditor@medicaltechoutlook.comThe COVID-19 pandemic has negatively impacted the cardiovascular market as non-urgent cardiovascular procedures were postponed and delayed. However, there are several drivers expected to boost market growth such as the rising global burden of various coronary diseases. In fact, the total global cost of cardiovascular disease treatment is set to reach USD 1044 billion by 2030. Technologies used in the cardiovascular device development have improved significantly over the past decade and the indications for these devices have expanded. On the diagnostic and monitoring font, a new generation of portable and compact ECGs is driving its adoption, especially in the home healthcare segment. These devices allow doctors to monitor and diagnose a patient remotely on time. Artificial intelligence has had a significant impact on cardiology with improved capabilities to diagnose certain heart conditions. Other new technologies in cardiovascular devices are wearable smart devices equipped with heart-monitoring capabilities such as bands, watches, and rings. The introduction of advanced endoscopic vessel harvesting technologies in coronary artery bypass graft surgery has offered an effective treatment solution with high patient satisfaction. In this edition of MedTech Outlook, we bring you the story of some of the most successful cardiovascular devices companies that deliver the best outcomes for their clients. This edition also offers a combination of thought leadership from subject matter experts with real-life stories on fostering robust partnerships and exclusive insights from CXOs. We hope this edition will provide you the assistance in choosing the right cardiovascular devices company according to your requirements.Let us know your thoughts!Technological Advancement in Cardiovascular DevicesSarah FernandesEDITORIAL
< Page 5 | Page 7 >